Detalles de la búsqueda
1.
NLRP4 negatively regulates type I interferon response and influences the outcome in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy.
Cancer Sci
; 113(3): 838-851, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927309
2.
Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction.
Exp Cell Res
; 406(1): 112724, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237300
3.
Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.
Int J Gen Med
; 17: 161-174, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268861
4.
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.
Pharmgenomics Pers Med
; 16: 219-228, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36960215
5.
LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity.
Redox Biol
; 66: 102860, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633049
6.
Ischemic Preconditioning Alleviates Mouse Renal Ischemia/Reperfusion Injury by Enhancing Autophagy Activity of Proximal Tubular Cells.
Kidney Dis (Basel)
; 8(3): 217-230, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35702707
7.
Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.
Front Genet
; 13: 997573, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263417
8.
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer.
Med Oncol
; 39(3): 37, 2022 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059863
9.
Early-like differentiation status of systemic PD-1+CD8+ T cells predicts PD-1 blockade outcome in non-small cell lung cancer.
Clin Transl Immunology
; 11(7): e1406, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35910005
10.
Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment.
Front Oncol
; 12: 927410, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387134
11.
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.
Int J Gen Med
; 14: 8651-8666, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34849009
12.
Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer.
Sci China Life Sci
; 64(10): 1590-1601, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33521853
13.
Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer.
Front Mol Biosci
; 8: 678753, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34095230
14.
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
Front Immunol
; 11: 576603, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329543
15.
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
Technol Cancer Res Treat
; 18: 1533033819876601, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558111
Resultados
1 -
15
de 15
1
Próxima >
>>